About biotricity inc - BTCY
Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. Its products include Bioflux, Biocore, Bioheart, Biokit, and Biocare. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on January 25, 2011 and is headquartered in Redwood City, CA.
BTCY At a Glance
Biotricity, Inc.
203 Redwood Shores Parkway
Redwood City, California 94065
| Phone | 1-800-590-4155 | Revenue | 16.00M | |
| Industry | Packaged Software | Net Income | -2,404,139.00 | |
| Sector | Technology Services | 2026 Sales Growth | 16.011% | |
| Fiscal Year-end | 03 / 2027 | Employees | 46 | |
| View SEC Filings |
BTCY Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.403 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 16.215 |
| Enterprise Value to Sales | 2.192 |
| Total Debt to Enterprise Value | 0.772 |
BTCY Efficiency
| Revenue/Employee | 347,787.804 |
| Income Per Employee | -52,263.891 |
| Receivables Turnover | 5.455 |
| Total Asset Turnover | 2.647 |
BTCY Liquidity
| Current Ratio | 0.158 |
| Quick Ratio | 0.122 |
| Cash Ratio | 0.004 |
BTCY Profitability
| Gross Margin | 80.939 |
| Operating Margin | 10.571 |
| Pretax Margin | -15.028 |
| Net Margin | -15.028 |
| Return on Assets | -39.779 |
| Return on Equity | N/A |
| Return on Total Capital | 40.757 |
| Return on Invested Capital | N/A |
BTCY Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | -458.808 |
| Total Debt to Total Assets | 419.822 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | -14.763 |